Long-Term Outcomes following Repair or Replacement in Degenerative Mitral Valve Disease

Abstract

Background: We studied whether mitral valvuloplasty (MVP) was superior to mitral valve replacement (MVR) in patients with degenerative mitral regurgitation (MR), and analyzed the independent risk factors for survival and reoperation. Methods: 326 patients with degenerative MR underwent MVP (n = 241), mitral valve replacement (MVR) (n = 78) or emergent MVR due to failure of repair (EMVR). Clinical data were analyzed retrospectively. Results: Thirty-day mortality was lower after MVP (2.5 %) compared to MVR (9.0 %) (p < 0.05). Late survival at 1 and 5 years in the MVP group was 94.4 % and 84.3 % versus 80.4 % and 64.6 % in the MVR group (p < 0.05), respectively. After adjusting the baseline characteristics by the propensity score method, a significant survival benefit was found for patients who underwent MVP. Multivariable analysis showed that MVR was an independent predictor of thirty-day mortality and survival. There was no significant difference in thirty-day mortality and survival between the EMVR and MVR groups. The need for reoperation was not significantly different between the MVP and MVR groups. In the MVP group, the risk factors for survival and reoperation were identified. Conclusions: MVP is superior to MVR for the treatment of degenerative MR despite the impact of repair failure. Age less than 60 years, ring size to body surface area greater than 19.0, absence of a prosthetic ring and residual MR at the end of surgery (≥ 1/4) reduce the durability of MVP.

Key words

mitral valve repair - mitral valve replacement - reoperation - survival analysis - risk analysis/modeling

Reference

• 1 Carpentier A. Reconstructive valvuloplasty. A new technique of mitral valvuloplasty.  Presse Med. 1969;  77 251-253
• 2 Gillinov A M, Cosgrove D M, Blackstone E H et al. Durability of mitral valve repair for degenerative disease.  J Thorac Cardiovasc Surg. 1998;  116 734-743
• 3 Mohty D, Orszulak T A, Schaff H V, Avierinos J F, Tajik J A, Enriquez-Sarano M. Very long-term survival and durability of mitral valve repair for mitral valve prolapse.  Circulation. 2001;  104 (Suppl. I) I1-I7
• 4 De Bonis M, Lorusso R, Lapenna E et al. Similar long-term results of mitral valve repair for anterior compared with posterior leaflet prolapse.  J Thorac Cardiovasc Surg. 2006;  131 364-370
• 5 Flameng W, Herijgers P, Bogaerts K. Recurrence of mitral valve regurgitation after mitral valve repair in degenerative valve disease.  Circulation. 2003;  107 1609-1613
• 6 David T E. Outcomes of mitral valve repair for mitral regurgitation due to degenerative disease.  Semin Thorac Cardiovasc Surg. 2007;  19 116-120
• 7 Dumont E, Gillinov A M, Blackstone E H et al. Reoperation after mitral valve repair for degenerative disease.  Ann Thorac Surg. 2007;  84 444-450
• 8 David T E, Ivanov J, Armstrong S, Christie D, Rakowski H. A comparison of outcomes of mitral valve repair for degenerative disease with posterior, anterior, and bileaflet prolapse.  J Thorac Cardiovasc Surg. 2005;  130 1242-1249
• 9 Gillinov A M, Faber C, Houghtaling P L et al. Repair versus replacement for degenerative mitral valve disease with coexisting ischemic heart disease.  J Thorac Cardiovasc Surg. 2003;  125 1350-1362
• 10 Thourani V H, Weintraub W S, Guyton R A et al. Outcomes and long-term survival for patients undergoing mitral valve repair versus replacement: effect of age and concomitant coronary artery bypass grafting.  Circulation. 2003;  108 298-304
• 11 Suri R M, Schaff H V, Dearani J A et al. Survival advantage and improved durability of mitral repair for leaflet prolapse subsets in the current era.  Ann Thorac Surg. 2006;  82 819-826
• 12 Miller D C. Ischemic mitral regurgitation redux – to repair or to replace?.  J Thorac Cardiovasc Surg. 2001;  122 1059-1062
• 13 Edmunds Jr L H, Clark R E, Cohn L H, Grunkemeier G L, Miller D C, Weisel R D. Guidelines for reporting morbidity and mortality after cardiac valvular operations. The American Association for Thoracic Surgery, Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity.  Ann Thorac Surg. 1996;  62 932-935
• 14 Scorsin M, Al-Attar N, Lessana A. A novel technique of utilizing artificial chordae for repair of mitral valve prolapse.  J Thorac Cardiovasc Surg. 2007;  134 1072-1073
• 15 Seeburger J, Kuntze T, Mohr F W. Gore-Tex chordoplasty in degenerative mitral valve repair.  Semin Thorac Cardiovasc Surg. 2007;  19 111-115
• 16 Rodríguez E, Kypson A P, Moten S C, Nifong L W, Chitwood Jr W R. Robotic mitral surgery at East Carolina University: a 6 year experience.  Int J Med Robot. 2006;  2 211-215
• 17 David T E, Ivanov J, Armstrong S, Rakowski H. Late outcomes of mitral valve repair for floppy valves: implications for asymptomatic patients.  J Thorac Cardiovasc Surg. 2003;  125 1143-1152
• 18 Lee E M, Shapiro L M, Wells F C. Superiority of mitral valve repair in surgery for degenerative mitral regurgitation.  Eur Heart J. 1997;  18 655-663
• 19 Meyer M A, von Segesser L K, Hurni M, Stumpe F, Eisa K, Ruchat P. Long-term outcome after mitral valve repair: a risk factor analysis.  Eur J Cardiothorac Surg. 2007;  32 301-307
• 20 Alexiou C, Doukas G, Oc M et al. The effect of preoperative atrial fibrillation on survival following mitral valve repair for degenerative mitral regurgitation.  Eur J Cardiothorac Surg. 2007;  31 586-591
• 21 American College of Cardiology/American Heart Association Task Force on Practice Guidelines et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.  Circulation. 2006;  114 e84-e231
• 22 Lim E, Barlow C W, Hosseinpour A R et al. Influence of atrial fibrillation on outcome following mitral valve repair.  Circulation. 2001;  104 159-163
• 23 Barlow C W, Ali Z A, Lim E, Barlow J B, Wells F C. Modified technique for mitral repair without ring annuloplasty.  Ann Thorac Surg. 2003;  75 298-300
• 24 Duebener L F, Wendler O, Nikoloudakis N, Georg T, Fries R, Schäfers H J. Mitral-valve repair without annuloplasty rings: results after repair of anterior leaflet versus posterior-leaflet defects using polytetrafluoroethylene sutures for chordal replacement.  Eur J Cardiothorac Surg. 2000;  17 206-212
• 25 Maisano F, La Canna G, Grimaldi A et al. Annular-to-leaflet mismatch and the need for reductive annuloplasty in patients undergoing mitral repair for chronic mitral regurgitation due to mitral valve prolapse.  Am J Cardiol. 2007;  99 1434-1439
• 26 Bolling S F, Deeb G M, Brunsting L A, Bach D S. Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy.  J Thorac Cardiovasc Surg. 1995;  109 682-683
• 27 Gillinov A M, Wierup P N, Blackstone E H et al. Is repair preferable to replacement for ischemic mitral regurgitation?.  J Thorac Cardiovasc Surg. 2001;  122 1125-1141
• 28 Bolling S F, Pagani F D, Deeb G M, Bach D S. Intermediate-term outcome of mitral reconstruction in cardiomyopathy.  J Thorac Cardiovasc Surg. 1998;  115 381-386
• 29 Adams D H, Anyanwu A C, Rahmanian P B, Abascal V, Salzberg S P, Filsoufi F. Large annuloplasty rings facilitate mitral valve repair in Barlow's disease.  Ann Thorac Surg. 2006;  82 2096-2100
• 30 Gazoni L M, Fedoruk L M, Kern J A et al. A simplified approach to degenerative disease: triangular resections of the mitral valve.  Ann Thorac Surg. 2007;  83 1658-1664
• 31 Flameng W, Meuris B, Herijgers P, Herregods M C. Durability of mitral valve repair in Barlow disease versus fibroelastic deficiency.  J Thorac Cardiovasc Surg. 2008;  135 274-282